Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-17-000591

Options or other derivatives

  • Director bought 0 shares

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rai Dhruwa N Director 2017-03-02 Purchase · 8% Convertible Note due March 2020 +0 $1,000,000.00 $0 D
Loading xslF345X03/form410211002_03062017.xml…